Skip to main content
. 2017 Feb 10;8:14345. doi: 10.1038/ncomms14345

Figure 2. Topical tacrolimus decreases inflammation after lymphatic injury.

Figure 2

(ac) Representative × 40 images of tail tissue sections from control and topical tacrolimus-treated animals 6 weeks after surgery with immunofluorescent localization of CD45+(a), CD4+ cells (b) and IFN-γ+ cells (c). Lymphatic vessels are stained for LYVE-1+ (red) in each figure. Quantifications of positive cell per 0.25 mm2 area (four random areas per mouse) for both early and late treatments are shown to the right of each figure (P<0.001 for all; n=8/group). Experiments were repeated two to three times. All data represent mean±s.d. with P≤0.05 considered as significant. Data analysed by two-tailed Student's t-test. Scale bars, 100 μm.